Literature DB >> 12767738

Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer.

Thomas Guttuso1, Joseph Roscoe, Jennifer Griggs.   

Abstract

In an anecdotal report, complete resolution of chemotherapy-induced nausea was seen in a patient with breast cancer, after she was placed on the anticonvulsant gabapentin. On this basis, we did an open-label study in which oral gabapentin 300 mg thrice daily was given for every other chemotherapy treatment in nine patients with breast cancer. Six of the nine reported at least a three-point improvement in peak delayed nausea (on an eight-point nausea scale), and three patients had complete resolution of nausea when taking gabapentin. This preliminary evidence shows that gabapentin might have a role in treatment of chemotherapy-induced nausea.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767738     DOI: 10.1016/S0140-6736(03)13365-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  19 in total

Review 1.  Central Aspects of Nausea and Vomiting in GI Disorders.

Authors:  Prashant Singh; Braden Kuo
Journal:  Curr Treat Options Gastroenterol       Date:  2016-12

2.  Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.

Authors:  Thaiana Aragão Santana; Damila Cristina Trufelli; Leandro Luongo de Matos; Felipe Melo Cruz; Auro Del Giglio
Journal:  Support Care Cancer       Date:  2014-08-22       Impact factor: 3.603

3.  Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance).

Authors:  Debra L Barton; Gita Thanarajasingam; Jeff A Sloan; Brent Diekmann; Jyotsna Fuloria; Lisa A Kottschade; Alan P Lyss; Anthony J Jaslowski; Miroslaw A Mazurczak; Scott C Blair; Shelby Terstriep; Charles L Loprinzi
Journal:  Cancer       Date:  2014-07-09       Impact factor: 6.860

4.  Gabapentin for the prevention of chemotherapy- induced nausea and vomiting: a pilot study.

Authors:  Felipe Melo Cruz; Daniel de Iracema Gomes Cubero; Patrícia Taranto; Tatiana Lerner; Andrea Thaumaturgo Lera; Michele da Costa Miranda; Mariana da Cunha Vieira; Angelo Bezerra de Souza Fêde; Fernanda Schindler; Mércia Maleckas Carrasco; Samuel Oliveira de Afonseca; Hélio Pinczowski; Auro del Giglio
Journal:  Support Care Cancer       Date:  2011-04-05       Impact factor: 3.603

Review 5.  Current pharmacotherapy for chemotherapy-induced nausea and vomiting in cancer patients.

Authors:  Michelle C Janelsins; Mohamedtaki A Tejani; Charles Kamen; Anita R Peoples; Karen M Mustian; Gary R Morrow
Journal:  Expert Opin Pharmacother       Date:  2013-04       Impact factor: 3.889

Review 6.  Nausea: a review of pathophysiology and therapeutics.

Authors:  Prashant Singh; Sonia S Yoon; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2016-01       Impact factor: 4.409

Review 7.  Management of chemotherapy-induced nausea and vomiting : focus on newer agents and new uses for older agents.

Authors:  Rudolph M Navari
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

8.  Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements?

Authors:  Shivani Shinde; Pamela Gordon; Prashant Sharma; James Gross; Mellar P Davis
Journal:  Support Care Cancer       Date:  2014-08-29       Impact factor: 3.603

Review 9.  Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments.

Authors:  Rudolph M Navari
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 10.  Gabapentin's anti-nausea and anti-emetic effects: a review.

Authors:  Thomas Guttuso
Journal:  Exp Brain Res       Date:  2014-03-26       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.